Avantor, Inc. announced that R. Brent Jones will join the company as Executive Vice President, effective August 7, 2023. Over a nearly 30-year career, Mr. Jones has served as chief financial officer for several public and private life sciences companies and, previously, as a senior investment banker. He is currently Executive Vice President, Chief Financial Officer and Chief Operating Officer at LifeScan Global Corporation, where he is responsible for all aspects of LifeScan's global finance and operations functions.

As Chief Financial Officer and a member of Avantor's Executive Leadership Team, Mr. Jones will lead Avantor's global finance organization and financial activities including accounting and controllership, financial planning and analysis, tax, investor relations, internal audit, and treasury. Thomas A. Szlosek, Avantor's current Chief Financial Officer will serve in such position through August 4, 2023, at which time he will begin a new role outside the life sciences industry. Mr. Jones brings to Avantor significant experience enhancing operational and financial results, building efficient and effective teams, and leading strategic and financing transactions.

Since 2020, Mr. Jones has served as CFO of LifeScan, where he oversees key areas including commercial finance, corporate reporting, FP&A, investor relations, operations finance, tax, and treasury. He was promoted to Chief Financial and Operating Officer in 2023. Prior to LifeScan, Mr. Jones was CFO at Klöckner Pentaplast Group.

He was previously the interim CFO of Pall Corporation, where he led the company's sale to Danaher for $13.8 billion in 2015. He spent the first 15 years of his career in investment banking with several firms including Merrill Lynch, Bank of America, and corporate law with Cravath, Swaine, & Moore. Mr. Jones holds an A.B. in Biochemistry and Asian Studies from Dartmouth College and a J.D. from Yale Law School.